Specialist Updates 
Rheumatology

Bid to retool arthritis drug for COVID-19 fails

But trials of the agent are continuing in the UK in sicker patients
Reuters Health
0
3 August 2020
Save
ClosePlease login
Coronavirus particle

An attempt by the Swiss pharmaceutical company Roche to retool its rheumatoid arthritis drug tocilizumab to treat patients with severe coronavirus-related pneumonia has failed in a late-stage trial, the company has announced.

The 452-patient COVACTA trial was launched in March as Roche joined other pharmaceutical companies seeking to repurpose existing medicines to fight the pandemic.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .